| Data source | AI use case | Planning use |
|---|---|---|
| Electronic health records (EHRs) | Real-time clinical decision support that analyzes patient data and medical literature | The usual starting point for decision support. Check first whether your systems exchange data cleanly, because many healthcare systems and devices do not communicate seamlessly. |
| Medical imaging (X-rays, MRIs, CT scans) | Deep learning software that sharpens images, one example of an AI-enabled device function | Treat imaging AI as a regulated device purchase. Confirm its FDA status and intended use before you plan a pilot. |
| Genomics | Identifying genetic markers associated with diseases in massive genomic datasets | Suits research and precision-medicine programs. Plan privacy review at the start, not after the data is pooled. |
| Wearables, medical sensors, social media, clinical trials, administrative databases | Additional streams pooled with records and images to widen what models can learn from | Budget for normalization and quality checks, because incomplete or erroneous data can lead to incorrect conclusions. |
The data sources and use cases above come from the Big Data Framework’s healthcare overview and the FDA’s page on AI-enabled medical devices.
AI and big data in healthcare work as a pipeline: varied patient data feeds machine learning models that support detection, diagnosis and treatment, provided data quality, privacy compliance and clinician review hold at every stage.
This guide follows that pipeline from source to governance. It sits within the broader question of how is biotechnology used in medicine, which the biotech in healthcare hub answers.
What the pipeline changes for care teams
The practical effect of pairing AI with big data is that decisions can draw on far more information than one clinician can hold in mind. The FDA notes that AI-enabled medical devices can analyze large and complex datasets, identify patterns, and generate information that supports detection, diagnosis and treatment. A Harvard T.H. Chan School of Public Health event on AI and health care data heard from panelists who integrate AI into diagnostics, patient monitoring and clinical decision-making.
That breadth means the first decision is where to apply it. The right choice depends on what your data can support and on how much regulatory weight the tool will carry.
- Decision support on EHR data: Big data analytics can give healthcare professionals real-time decision support by analyzing patient data and medical literature. Choose this when clinicians can see why a recommendation was made, which also matters for how the FDA treats the software.
- Imaging tools: Pick these when you already hold imaging data and can handle the device-purchase process, since the FDA regulates AI-enabled imaging software as a medical device.
- Genomic analysis: Choose this for research or precision-medicine goals, where large genomic datasets are used to find genetic markers associated with disease.
- Scheduling and billing tools: These suit organizations seeking quick operational wins, because the FDA does not typically regulate AI used for administrative tasks such as scheduling or billing. Privacy duties still apply to the data they use.
Whichever route you choose, results depend on the inputs. The next section covers where those inputs come from and where they fail.
Data sources and where they break
Healthcare data comes from electronic health records, wearable devices, medical sensors, social media, medical imaging, clinical trials and administrative databases. The same overview describes the variety as structured, semi-structured and unstructured data, with genomic data, medical images and speech recordings adding to it.
Variety is the first pipeline problem. Each format needs its own handling before a model can learn from it, so a project that begins with only structured EHR fields is easier to launch than one that pools everything at once.
Data quality
The Big Data Framework warns that incomplete or erroneous data can lead to incorrect conclusions and potentially harm patients. A model cannot compensate for missing or wrong inputs, so quality checks belong at ingestion, before training begins.
Interoperability
Many healthcare systems and devices do not communicate seamlessly, which creates interoperability problems for any pipeline that draws on more than one system. If your EHR and device feeds cannot exchange data reliably, fix that before you evaluate model vendors.
Imaging, genomics and decision support in practice
Machine learning earns its place where the data is too large or complex for manual review. In imaging, the FDA gives the example of software that uses deep learning to sharpen images. In genomics, analytics can scan massive datasets for genetic markers associated with diseases, as the Big Data Framework describes.
Genomic analysis is also one input to personalized treatment. Lab-based approaches are another route, covered in Patient-Derived Organoids: How Lab-Grown Mini-Organs Are Transforming Personalized Cancer Care – Biolifetechnologies. Where genomic findings point toward advanced therapies, How Much Does Gene Therapy Cost? A Practical 2026 Cost Guide For Patients And Families – Biolifetechnologies explains what families may face financially.
Privacy rules for health data
HIPAA, the Health Insurance Portability and Accountability Act, is the compliance framework the Big Data Framework names as critical for health data. It lists HIPAA and GDPR (the General Data Protection Regulation) as examples of the laws that apply, and adds that other laws may also apply. Which obligations bind you depends on whose data you hold and where.
For planning, map each data source to the privacy obligations that govern it before pooling. Genomic, imaging and device data may each raise different questions, and the Harvard panel on AI and your health care data addressed data privacy and protection as a core concern alongside clinical integration. Bring your privacy or compliance officer into design discussions rather than into a final sign-off.
FDA oversight of healthcare AI software
The FDA states that it does not regulate AI as such; it regulates medical devices, including AI-enabled ones. Its database lists over 1,600 AI-enabled devices authorized for marketing in the United States as of September 2026. A Bipartisan Policy Center brief counted over 1,250 as of July 2025, up from 950 as of August 2024, so the market for cleared tools is growing.
Which software counts as a device
The FDA says the term device includes software, except for certain functions excluded under section 520(o) of the Federal Food, Drug, and Cosmetic Act. The Bipartisan Policy Center explains that software is a medical device when it is intended for use in the diagnosis, cure, mitigation, treatment or prevention of disease, under section 201(h). It also describes two categories of regulated software: Software as a Medical Device (SaMD), which is standalone, and Software in a Medical Device (SiMD), which is embedded in hardware. Intended use, not the presence of AI, drives the classification.
The clinical decision support exclusion
The 21st Century Cures Act narrowed FDA authority over certain health software. Some clinical decision support (CDS) is excluded when it supports rather than replaces clinical decisions. A key criterion is that the software must let providers independently review and understand the basis for its recommendations. The brief adds that the CDS guidance indicates tools used in time-sensitive situations, or relying on complex, nontransparent algorithms, may not qualify for the exclusion. If a vendor says its tool is exempt, ask how a clinician can inspect the reasoning.
Premarket routes and change control
For devices that are regulated, the FDA applies a risk-based approach that considers intended use and technological characteristics. Routes include 510(k) premarket clearance, De Novo classification or premarket approval. A marketing submission may include a Predetermined Change Control Plan (PCCP), which matters for models that will be updated after launch. The FDA frames oversight across the whole lifecycle, from development and validation through deployment, monitoring, maintenance and modification.
Starting an implementation
A sound start follows the pipeline and the regulatory facts above. Use these steps as a sequence.
- Inventory your data. List the structured, semi-structured and unstructured sources you hold, and note which formats a pilot would need.
- Test system connections. Confirm that your EHR, device and imaging systems can exchange data, since interoperability gaps are a known barrier.
- Set quality checks. Define how incomplete or erroneous records are caught before they reach a model.
- Classify the tool. Decide whether the software is intended for diagnosis, treatment or prevention, or is administrative, and whether any CDS exclusion could apply.
- Map privacy duties. Match each source to HIPAA, GDPR or other obligations with your compliance officer.
- Plan for the full lifecycle. Assign responsibility for validation, deployment, monitoring and maintenance, and ask vendors whether a change control plan exists.
Starting with an administrative or EHR-based decision-support pilot is usually simpler than a genomic or imaging program, because it involves fewer data formats and, for administrative tools, typically less regulatory exposure.
Frequently asked questions
What data sources feed healthcare AI?
EHRs, wearables, medical sensors, social media, imaging, clinical trials and administrative databases all contribute, along with genomic data and speech recordings.
What privacy rules apply to health data?
HIPAA is a central one in the United States, and GDPR applies where its scope reaches. Other laws may also apply, depending on the data and jurisdiction.
Does the FDA regulate every healthcare AI tool?
No. The FDA regulates medical devices, and software counts when it is intended for diagnosis, treatment or prevention of disease. Administrative tools such as scheduling or billing are not typically regulated, and some decision support can be excluded.
How do health systems start implementing AI on big data?
They begin by checking data quality and system interoperability, then classify the intended use, map privacy obligations and plan monitoring across the tool’s lifecycle.
